Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TETON-PPF phase 3 trial of inhaled treprostinil in progressive pulmonary fibrosis
MOH_2024-08-22_013598Phase 3Not yet recruiting
- Sponsor
- United Therapeutics Corporation
- Start
- Jul 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in pulmonary fibrosis (PF) comparing Inhaled treprostinil with Placebo (2 arms). Primary endpoint: Primary endpoint not provided. Planned start Jul 2024; status: not yet recruiting.
02
Drugs
treprostinil
03
Conditions
pulmonary fibrosis (PF)
Beyond the preview
Go deeper on MOH_2024-08-22_013598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2024-08-22_013598.